what-when-how
In Depth Tutorials and Information
was 4 weeks. The analgesic effect of iloprost and tra-
madol was similar. BME regression on MR images was
more pronounced under iloprost treatment. On MR
images, 3 months after initiating treatment, complete
BME regression in at least one bone was observed in nine
patients (52.9%) in group 1, as opposed to three patients
(18.7%) in group 2.
Meiser treated individuals with edema of the femur
head with a series of five iloprost infusions, 20 to 50 μg
iloprost over 6 hours on 5 consecutive days each. 33 At
clinical follow-up 4 months after therapy, the pain level
at rest had diminished by a mean of 58.3%. Pain under
stress decreased by a mean of 41.9% ( P <0.0001). On
MRI, 20 patients had a significant reduction of BME size
or complete normalization and four showed no change.
Worsening of the MRI pattern was found in three
patients.
with transient osteporosis. Rev Esp Anestesiol Reanim
2010;57(5):319-20.
[10]
Emami MJ, Abdollahpour HR, Kazemi AR, Vosoughi AR.
Bilateral subcapital femoral neck fractures secondary to tran-
sient osteoporosis during pregnancy: a case report. J Orthop
Surg 2012;20(2):260-2.
[11]
Karagkevrekis CB, Ainscow DAP. Transient osteoporosis of the
hip associated with osteogenesis imperfecta. J Bone Joint Surg
1998;80:54-5.
[12]
Miltner O, Niedhart C, Piroth W, Weber M. Transient
Osteoporosis of the navicular bone in a runner. Arch Orthop
Trauma Surg 2003;123:505-8.
[13]
Stanton-Hicks MD, Burton AW, Bruehl SP, Carr DB, Harden RN,
Hassenbusch SJ, et  al. An updated interdisciplinary clinical path-
way for CRPS: report of an expert panel. Pain Pract 2002;2(1):1-16.
[14]
Banas MP, Kaplan FS, Fallon MD, Haddad JG. Regional migra-
tory osteoporosis. A case report and review of the literature.
Clin Orthop Relat Res 1990;250:303-9.
[15]
Kim SY, Koo KH, Suh KT, Kim YS, Cho YJ, Min BW, et al. Fatty
marrow conversion of the proximal femoral metaphysis in tran-
sient bone marrow edema syndrome. Arch Orthop Trauma Surg
2005;125(6):390-5.
[16]
Trevisan C, Ortolani S, Monteleone M, Marinoni E. Regional migra-
tory osteoporosis: a pathogenetic hypothesis based on three cases
and a review of the literature. Clin Rheumatol 2002;21:418-25.
CONCLUSION
[17]
Frost HM. Perspectives: bone's mechanical usage windows.
Bone Miner 1992;19:257-71.
TMO affects both females and males, the former usu-
ally in the context of pregnancy and the latter in middle
age. The disorder is self-limiting and reversible, but has
a potentially significant impact on patients with OI by
virtue of increasing disability. The real incidence in the
OI population is unknown. This disorder should be
considered in OI patients who experience rapid onset of
hip pain or pain in other joints. Prompt diagnosis and
treatment may lessen the pain, improve function and
promote resolution of bone edema seen on MRI.
[18]
Miyanishi K, Kaminomachi S, Hara T, Maeda H, Watanabe H,
Shimizu A, et al. A subchondral fracture in transient osteoporo-
sis of the hip. Skeletal Radiol 2007;36(7):677-80.
[19]
Noorda RJP, van der Aa JPW, Wuisman PJM, David EFL, Lips
PTAM, van der Valk P. Transient osteoporosis and osteogenesis
imperfecta. Clin Orthop Relat Res 1997;337:249-55.
[20]
McCarthy EF. The pathology of transient regional osteoporosis.
Iowa Orthop J 1998;18:35-42.
[21]
Hofmann S, Engel A, Neuhold A, Leder K, Kramer J, Plenk HJ.
Bone-marrow oedema syndrome and transient osteoporosis of
the hip. An MRI-controlled study of treatment by core decom-
pression. J Bone Joint Surg Br 1993;72(2):210-6.
References
[1] Curtiss PHJ, Kincaid WE. Transitory demineralization of the
hip in pregnancy. A report of three cases. J Bone Joint Surg Am
1959;41-A:1327-33.
[2] Lequesne M. Osteoporosis of the hip. A non-traumatic variety of
Sudeck's atrophy. Ann Rheum Dis 1968;27:463-71.
[3] Arayssi TK, Tawbi HA, Usta IM, Hourani MH. Calcitonin in the
treatment of transient osteoporosis of the hip. Semin Arthritis
Rheum 2003;32:388-97.
[4] Weitzel SH, Percy AJ. Transient osteoporosis of the hip associ-
ated with pregnancy and osteogenesis imperfecta. Orthopedics
2000;23:1291-2.
[5] Cahir JG, Toms AP. Regional migratory osteoporosis. Eur
J Radiol 2008;67(1):2-10.
[6] Trevisan C, Ortolani S. Bone loss and recovery in regional
migratory osteoporosis. Osteoporos Int 2002;13(11):901-6.
[7] Varenna M, Zucchi F, Binelli L, Failoni S, Gallazzi M, Sinigaglia L.
Intravenous pamidronate in the treatment of transient osteoporo-
sis of the hip. Bone 2002;31:96-101.
[8] Young SD, Nelson CL, Steinberg ME. Transient osteoporo-
sis of the hip in association with osteogenesis imperfecta: two
cases, one complicated by a femoral neck fracture. Am J Orthop
2008;37(2):88-91.
[9] San Juan Alvarez M, Márquez Garrido G, Rodríguez Bertos C,
González Pérez L. Hip fracture during pregancy in a woman
[22]
Kostantinos NM, Zibis A, Dailana Z. MR Imaging indings in
transient osteoporosis of the hip. Eur J Radiol 2004;50:238-44.
[23]
Balakrishnan A, Schemitsch EH, Pearce D, McKee MD.
Distinguishing transient osteoporosis of the hip from avascular
necrosis. Can J Surg 2003;46:187-92.
[24]
Guerra JJ, Steinberg ME. Distinguishing transient osteopo-
rosis from avascular necrosis of the hip. J Bone Joint Surg Am
1995;77(4):616-24.
[25]
Tan TX, Dardani M, Neal DJ, Mueller CF, Pozderac RV. Atypical
indings of discordant bone scan and radiographs in transient
osteoporosis of the hip: case report and review of the literature.
Clin Nucl Med 1998;23(3):160-2.
[26]
Pabinger C, Heu C, Frohner A, Dimai HP. Pregnancy- and
lactation-associated transient osteoporosis of both hips in a
32-year-old patient with osteogenesis imperfecta. Bone 2012;
51(1):142-4.
[27]
Boos S, Sigmund G, Huhle P, Nurbakhsch I. Magnetic resonance
tomography of so-called transient osteoporosis. Primary diag-
nosis and follow-up after treatment. Rofo 1993;158(3):201-6.
[28]
Carmona-Ortells L, Carvajal-Méndez I, García-Vadillo JA,
Alvaro-Gracia JM, González-Alvaro I. Transient osteoporosis of
the hip: successful response to delazacort. Clin Exp Rheumatol
1995;13(5):653-5.
[29]
Fabbriciani G, Pirro M, Manfredelli MR, Bianchi M, Sivolella S,
Scarponi AM, et al. Transient osteoporosis of the hip: successful
treatment with teriparatide. Rheumatol Int 2012;32(5):1367-70.
 
Search WWH ::




Custom Search